Demography of Arabs and consanguinity
=====================================

The Arab countries comprise the 22 states and territories of the Arab League stretching from the Atlantic Ocean of North Africa in the west to the Arabian Sea of the Arabian Peninsula in the east. The incidence of congenital disorders among the 350 million inhabitants of these Arabic countries is influenced by their demographic and cultural characteristics. Most Arab populations are characterized by marriage at a young age, large extended family structure and advanced maternal and paternal ages. In addition, consanguineous marriages are favored, and intra-familial unions currently account for 20--60% of all marriages. Furthermore, first-cousin unions are popular and constitute almost one-quarter of all marriages.^[@bib1]^ Consequently, these marriage traditions have resulted in the unequal distribution of founder mutations in most Arab populations.^[@bib2]^ Moreover, isolated subpopulations with high levels of inbreeding have made the epidemiology of genetic disorders complicated. Consequently, some genetic conditions are confined to specific villages, families or tribal groups, and these communities face an increased burden of genetic disorders, particularly the rare autosomal recessive (AR) disorders.^[@bib3]^ Numerous AR genes and loci have been identified in Arab families, with the majority associated with consanguinity.^[@bib1],[@bib4],[@bib5]^

Joubert syndrome (JS) and Joubert syndrome-related disorders (JSRDs) are a large group of pleotropic conditions that affect different organs of the body. These conditions are characterized by dysgenesis of the cerebellar vermis and the appearance of the molar tooth sign (MTS)^[@bib6]^ via neuroimaging. The most common clinical features of JS and JSRDs include hypotonia, ataxia, intellectual disability (ID), developmental delay, eye movement impairment and neonatal breathing difficulties. In addition, these disorders might involve multiorgan abnormalities such as liver fibrosis, retinopathy, nephronophthisis, polydactyly and cystic dysplastic kidneys. The prognosis for individuals with JS and JSRDs vary widely depending on the extent and severity of organ involvement. The prevalence of JSRDs in the USA has been estimated to be 1:100,000.^[@bib7]^ However, this prevalence is likely to be an underestimate given the wide spectrum of clinical variability, particularly in individuals with milder symptoms.^[@bib8]^ The prevalence of JSRDs has not been well defined in most Arab countries. However, an incidence of 1:5,000 births has been reported for the UAE,^[@bib1]^ which is considerably higher than in the USA. JS and JSRDs have been found to be caused by defects in 23 genes (*INPP5E, TMEM216, AHI1, NPHP1, CEP290 (NPHP6), TMEM67 (MKS3), RPGRIP1L, ARL13B, CC2D2A, OFD1, TTC21B, KIF7, TCTN1, TCTN2, TMEM237, CEP41, TMEM138, C5orf42, TCTN3, ZNF423, TMEM231, CSPP1* and *PDE6D*). All the products of these genes have some ciliary role; therefore, JS and JRSDs are classified as ciliopathies. Primary cilia are found in most cell types, including the cells found in the brain, kidneys and liver, and appear to have important roles in cellular chemosensation, mechanosensation and signaling.

Historical and diagnostic criteria
==================================

JS was named after Dr Marie Joubert, who was the first to describe siblings from a large French-Canadian family with ID, ataxia, abnormal eye movement and agenesis of the cerebellar vermis presenting with episodic tachypnea.^[@bib9]^ Several years later, a pathognomonic midbrain--hindbrain abnormality, termed 'molar tooth sign (MTS)', was described via cranial magnetic resonance imaging of individuals with JS and JSRDs.^[@bib7],[@bib10; @bib11; @bib12]^ A comprehensive review of previously reported and novel patients with JS established the first diagnostic criteria for this condition in 1992.^[@bib13]^ Most recently, the term 'Joubert Syndrome and related disorders' has been adopted for a group of pleiotropic conditions that share the MTS characteristic, but may also have other distinctive features (see [Figure 1](#fig1){ref-type="fig"}).^[@bib11]^ MTS is defined as a complex brainstem malformation that reflects aplasia or marked hypoplasia of the cerebellar vermis, thickened and elongated superior cerebellar peduncles and a deepened interpeduncular fossa that is apparent on axial magnetic resonance imaging at the midbrain--hindbrain junction.^[@bib14]^ Based on a review by Saraiva and Baraitser in 1999, the primary diagnostic criteria of pure/classic JS include the following clinical features: (1) MTS on axial views from cranial magnetic resonance imaging images comprising cerebellar vermis hypoplasia, deepened interpeduncular fossa and thick, elongated superior peduncles; (2) ataxia and a variable degree of ID and developmental delay; (3) hypotonia in infancy; and (4) often one or both of the following clinical characteristics: irregular breathing in infancy (episodic neonatal apnea and/or tachypnea) and abnormal eye movements (nystagmus and/or oculomotor apraxia).^[@bib8; @bib9; @bib10],[@bib13],[@bib15; @bib16; @bib17]^ In addition, autism represents a relatively common component of JS.^[@bib18],[@bib19]^

Recently, a broad spectrum of JSRDs has been defined that encompasses pure JS associated with variable involvement of systematic abnormalities, including other central nervous anomalies, ocular coloboma, polydactyly of the hands and/or feet, liver fibrosis, cystic dysplastic kidneys, retinopathy and/or nephronophthisis.^[@bib11],[@bib20],[@bib21]^ In 2008, a novel classification of JSRDs based on additional secondary criteria, which involves mainly three organs (eye, kidney and liver), was suggested, resulting in the designation of six subgroups^[@bib16]^ as follows: (1) pure JS; (2) JS associated with retinopathy; (3) JS with renal involvement (either NPH or cystic dysplastic kidneys); (4) CORS: comprising JS with both retinal and renal involvement (JS + SLS); (5) COACH (MIM216360): including JS with both ocular coloboma and liver abnormalities; and (6) oral--facial--digital (OFD) VI (MIM277170): including JS with both orofacial and digital signs^[@bib16]^ ([Figure 1](#fig1){ref-type="fig"}).

The multi-systemic nature of the clinical features of JS and JSRDs
==================================================================

In addition to the distinctive MTS as the hallmark characteristic, JS and JSRDs are associated with a broad range of additional features affecting multiple systems, which are described briefly below.

Neurological features
---------------------

The cardinal neurological features of JSRDs are altered respiratory patterns in the neonatal period, abnormal ocular movements and hypotonia evolving into ataxia and developmental delay, which is also often associated with ID. Early hypotonia is observed in almost all JSRD patients during either the neonatal period or infancy. The association of hypotonia, along with other peculiar features such as an irregular breathing pattern and altered eye movements, should suggest the diagnosis of JSRD and prompt clinicians to request a brain magnetic resonance imaging. The typical respiratory abnormalities are represented either by short alternate episodes of apnea and hyperpnea or by episodic hyperpnea alone.^[@bib19]^ The presence of abnormal eye movements such as oculomotor apraxia (the most characteristic and frequent abnormalities and manifests as an inability to follow objects visually with compensatory head movements), decreased smooth pursuit and cancellation of the vestibulo-ocular reflex. Primary position nystagmus is also common, associated occasionally with strabismus and ptosis.^[@bib19]^ Developmental abilitiesare delayed in all JSRD patients to variable degrees of severity. Mild-to-severe ID is common; however, it is not a mandatory feature of JSRDs, and in exceptional cases, patients may have borderline or even normal intellect.^[@bib19]^ Speech dyspraxia is typical and likely due to the cerebellar malformation.^[@bib12]^ Behavioral disturbances, when present, include impulsivity,temper tantrums and autismin in a few reported children.^[@bib12]^ A wide range of central nervous system malformations have been reported associated with a higher incidence of epilepsy as rare feature of JSRDs.^[@bib19]^

Ophthalmological features
-------------------------

The retina is frequently affected in JSRDs, mostly in the form of retinal dystrophy. The clinical spectrum can range from congenital retinal blindness (Leber congenital amaurosis (LCA)) to retinal dystrophy characterized by a progressive course and variably conserved vision.^[@bib19]^ Colobomas mostly affect the posterior segment of the eye, but iris colobomas have also been reported.^[@bib19]^ Nystagmus is often present at birth and may improve with age. Strabismus, amblyopia and ptosis may require medical or surgical intervention. In addition, third nerve palsy has also been observed.^[@bib12]^

Renal features
--------------

Renal disease has been reported in patients with JSRDs, (25--30%)^[@bib12],[@bib19]^ and presents as nephronophthisis. Cystic dysplasia, multiple cysts of various sizes in immature kidneys with fetal lobulation, may be present at birth.^[@bib12]^ Juvenile nephronophthisis may remain asymptomatic for several years or present with subtle and often unrecognized signs, such as polyuria, polydipsia, anemia and growth failure. Acute or chronic renal insufficiency manifests either late in the first decade of life or early in the second. End-stage renal failure is usually reached by the end of the second decade, requiring dialysis or kidney transplantation.^[@bib19]^ An infantile variant of NPH manifests within the first years of life and takes a more rapid and severe course.^[@bib19]^

Hepatic features
----------------

Approximately 6% of JSRD patients present with liver disease^[@bib12]^ manifesting as congenital hepatic fibrosis.^[@bib12],[@bib19]^ Liver disease may present with elevated serum liver enzymes and early onset of hepatosplenomegaly or with more severe manifestations such as portal hypertension, esophageal varices and liver cirrhosis.^[@bib19]^ The association of JS with congenital hepatic fibrosis was previously referred to using the acronym COACH.^[@bib19]^

Skeletal features
-----------------

Skeletal defects may include polydactyly, which occurs in 8--16% of patients.^[@bib19]^ Postaxial polydactyly that variably affects the hands and feet is the most common type, but preaxial polydactyly of the toes is observed in some cases.^[@bib12],[@bib19]^ In addition, mesoaxial polydactyly has been described in rare cases, in which other signs of OFD-type VI syndrome (Varadi--Papp syndrome; OMIM 277170) are present.^[@bib12],[@bib19]^ Mild-to-severe scoliosis may manifest in JSRDs because of the degree of hypotonia in early infancy; structural anomalies of the vertebrae are uncommon.^[@bib19]^

Miscellaneous features
----------------------

Although JSRDs are not typically dysmorphic syndromes, a 'typical' dysmorphic facial appearance, including a broad forehead, arched eyebrows, ocular hypertelorism and open, tent-shaped mouth, has been observed. A recent study has outlined the presence of peculiar age-related cranio-facial features and distinct anthropometric facial patterns.^[@bib12],[@bib19]^ Oral frenula and tongue hamartomas have been described in the OFD VI group of disorders.^[@bib12]^ Endocrine abnormalities such as micropenis, isolated growth hormone deficiency or panhypopituitarism have been reported.^[@bib12]^ Congenital heart defects are not typically associated with JSRDs but have been reported occasionally.^[@bib12]^ Gastrointestinal system manifestations, including Hirschsprung\'s disease, have been described in a small number of JSRD patients.^[@bib19]^

Molecular aspects of JS and JSRDs in Arab families
==================================================

We focus on reviewing the mutation spectrum that causes JS and JSRDs in Arabs. Mutations in 15 out of 23 genes have been found in Arab patients with JSRDs ([Tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"}). [Table 2](#tbl2){ref-type="table"} summarizes the genes with pathogenic mutations in 72 Arab families with JSRDs identified so far. Details of these genes and the families are briefly described in the following section.

*INPP5E:* This gene encodes an inositol polyphosphate-5-phosphatase (EC 3.1.3.36) enzyme that has a role in regulating synaptic vesicle recycling, insulin signaling and embryonic development.^[@bib22]^ The INPP5E protein localizes to the primary cilia and is involved in signal transduction. The JBTS1 locus harboring INPP5E was first mapped in two Emirati families showing retinopathy and a proven MTS.^[@bib23],[@bib24]^ Knockdown of *Inppe5* in mice results in decreased primary cilia stability, leading to disorders in multiple organs, including the absence of eyes, polydactyly, exencephaly and renal cysts.^[@bib25]^ Homozygous mutations in 20 affected individuals from nine Arab families (three Egyptian, four Emirati, one Yemeni and one Algerian) have been reported^[@bib26]^ ([Table 2](#tbl2){ref-type="table"}). The major phenotypic features associated with *INPP5E* mutations include retinal disease associated with renal cystic disease and hepatic fibrosis.

*AHI1:* This gene encodes Jouberin, a component of a protein complex in the basal body that forms a barrier to restrict protein diffusion between the plasma and ciliary membranes in the transition zone at the base of cilia.^[@bib27]^ Jouberin is strongly expressed in the embryonic hindbrain and forebrain, suggesting a role in both cerebral and cortical development.^[@bib28]^ *Ahi1*-null mice displayed a hypoplastic cerebellum with an underdeveloped vermis and a mildly defective foliation pattern, similar to the clinical features of JBTS3 in humans.^[@bib29]^ Clinical analysis indicated that *AHI1* mutations were associated with retinal abnormalities ranging from retinitis pigmentosa (RP) to blindness; \~80% of patients presented with retinal dystrophy with no kidney or liver changes^[@bib16]^ ([Figure 1](#fig1){ref-type="fig"}). The proportion of JS patients with mutations in *AHI1* is estimated at 10%,^[@bib30],[@bib31]^ including 12 Arab families from Saudi Arabia, UAE, Kuwait, Egypt and Palestine ([Table 2](#tbl2){ref-type="table"}). Three different homozygous mutations in the *AHI1* gene were reported in three unrelated families living in the same geographical region of Saudi Arabia.^[@bib32]^

*CEP290:* This gene encodes a centrosomal protein of 290 kDa (known as nephrocystin-6) that localizes to the centrosome and cilia. Nephrocystin-6 is involved in renal cyst formation by modulating the activity of the ATF4 transcription factor. CEP290 interacts with other ciliary proteins such as CC2D2A and meckelin.^[@bib33; @bib34; @bib35]^ Knockdown of *cep290* in zebrafish resulted in abnormal cerebellar, renal, and retinal development, whereas naturally occurring mutations in rd16 mice and Abyssinian cats caused progressive retinal degeneration in the absence of renal or cerebellar defects.^[@bib36],[@bib37]^ To date, over 100 mutations have been identified in *CEP290*. Approximately 10% of JSRD patients have mutations in the *CEP290* gene and display a strong association for both retinal and renal involvement.^[@bib16]^ Eight different mutations have been identified in 13 Arab families. Mutations in this gene were the most common type found in the UAE, particularly the potential founder mutation p.G1890\* ([Table 2](#tbl2){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}).

*NPHP1:* This gene encodes nephrocystin-1, a protein that interacts with the AHI1 protein and other nephronophthisis disease-causing proteins, such as INVS, NPHP3 and NPHP4. Nephrocystin-1 localizes to the primary cilium, to cell--cell adherens junctions, and to the basal body, where it plays essential roles in the control of cell division and cell--cell and cell--matrix adhesion signaling.^[@bib38]^ Mutations in *NPHP1* result in JBTS4 characterized by JS and nephronophthisis. The MTS in these patients have a distinctive elongated appearance without thickened superior cerebellar peduncles.^[@bib31]^ A common \~290 kb deletion involving *NPHP1* has been associated with rare cases of JSRD.^[@bib39]^ In addition, some individuals with more severe phenotypes than nephronophthisis or SLS carry the homozygous *NPHP1* deletion as well as a heterozygous mutation in the *AHI1* or *CEP290* genes, suggesting that these genes contribute as modifiers.^[@bib39]^ This deletion appears to be absent or very rare among Arabs, as only one missense mutation (p.R48K) has been reported ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}).

TMEM family of genes (*TEME67, TMEM138, TMEM216, TMEM231 and TMEM237*)
----------------------------------------------------------------------

The tetraspanin super family (Tspan) of proteins contains over 30 genes^[@bib40; @bib41; @bib42]^ that regulate signaling pathways involved in cell adhesion, migration and fusion.^[@bib43],[@bib44]^ Most recently, five members of the TMEM family of proteins have been implicated in JS, JSRDs and other ciliopathies: *TMEM67, TMEM138, TMEM216, TMEM231* and *TMEM237*.^[@bib45]^

*TMEM67/MKS3*: This gene encodes the meckelin protein, which is expressed in the kidneys, liver, retina, hindbrain, developing sphenoid bone and the brain midline and is strongly expressed in the cartilage of developing limbs, particularly in the digits.^[@bib46]^ It was first discovered in five families with Meckel--Gruber syndrome (MIM [607361](http://www.omim.org/entry/607361?search=607361&highlight=607361)).^[@bib45]^ As reported by Romano *et al.*,^[@bib6]^ Baala *et al.* ^[@bib47]^ found mutations in *TMEM67* in two siblings with JS and designated this distinct form as JBTS6 (MIM [610688](http://www.omim.org/entry/610688?search=MIM%20610688&highlight=610688%20mim)). Moreover, mutations were identified in patients with the COACH syndrome (MIM [216360](http://www.omim.org/entry/216360?search=216360&highlight=216360)).^[@bib48; @bib49; @bib50]^ The clinical features of these patients were consistent with JS associated with congenital hepatic fibrosis, defining the COACH syndrome as subtype of JS with liver involvement. Of note, TMEM67 is involved in other forms of ciliopathy, such as Nephronophthisis 11, and as modifier gene for Bardet--Biedl syndrome. Interestingly, molecular analysis of patients with nephronophthisis and hepatic fibrosis (NPHP11; [\#212840](http://www.omim.org/entry/613550?search=613550&highlight=613550)) and a cohort of nephronophthisis cases without liver involvement showed that liver fibrosis is a specific feature of *TMEM67* mutations and is independent of neurological involvement^[@bib49]^ ([Figure 1](#fig1){ref-type="fig"}). Therefore, MKS3, JBTS6, COACH and NPHP11 represent a broad spectrum of allelic disorders caused by biallelic mutations in the *TMEM67* gene. To date, three different *TMEM67* mutations have been reported in families from Morocco, Algeria and Egypt ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}).*TMEM237/ALS2CR4*: This gene was originally described in the Hutterite population with Meckel syndrome.^[@bib51]^ However, some patients with JSRDs were found to have mutations in this gene.^[@bib51],[@bib52]^ JBTS14 is characterized by severe ID, abnormal breathing difficulties in infancy, MTS, renal cysts, abnormal eye movements and early death in many patients and is categorized as JS with oculorenal disease.^[@bib52]^ In addition, a distinctive optic disc anomaly was reported in a large Austrian family.^[@bib53]^ Encephalocele, hydrocephalus and cystic kidney disease are common in JBTS14 phenotype. Furthermore, *tmem237* knockdown in zebrafish caused gastrulation defects consistent with ciliary dysfunction, similar to defects resulting from knockdown of transition zone proteins, including Mks3 (TMEM67; MIM [609884](http://www.omim.org/entry/609884?search=609884&highlight=609884)) and Tmem216 (MIM [613277)](http://www.omim.org/entry/613277?search=613277&highlight=613277).^[@bib52]^ These findings suggest that TMEM237, TMEM216 and MKS3 function as a module to regulate ciliogenesis and WNT signaling.^[@bib52]^ Mutations in TMEM237 have been reported in three Arab families from Jordan, Saudi Arabia and the UAE ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}).*TMEM138*: The involvement of this gene was identified after the exclusion of *TMEM216* linked to the JBTS2 locus in six families.^[@bib54]^ Screening for mutations in positional genes identified homozygous mutations in TMEM138.^[@bib54]^ The JBTS16 phenotype was indistinguishable from that of JBTS2 by MTS, oculomotor apraxia, variable coloboma and rare kidney involvement.^[@bib54]^ Mutations in 20 individuals from 8 Arab families have been reported ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}).^[@bib54]^ Both the *TMEM138* and *TMEM216* genes are aligned in a head-to-tail orientation in higher vertebrates, with a conserved intergenic region,^[@bib54]^ which mediates the coordinated expression of TMEM138 and TMEM216 via the RFX4 protein.^[@bib54]^ The knockdown of *Tmem216* affects the vesicular trafficking of Tmem138 and Cep290, whereas the knockdown of *Tmem138* showed little effect on the vesicular movement of Tmem216.^[@bib54]^ Tmem138 localizes to the ciliary axoneme/basal body, while Tmem216 localizes to the basal body and the Golgi apparatus surrounding the base of cilium.^[@bib54]^ Both proteins localize to different vesicle pools that move toward the primary cilia over time.^[@bib54]^ Only Tmem138 vesicles showed co-localization with the endogenous Cep290 in IMCD3 cells.^[@bib54]^

*RPGRIP1L:* This gene encodes protein fantom, which localizes to the primary cilia and centrosomes in ciliated Madin-Darby canine kidney II cells.^[@bib55]^ Recent functional studies in *C. elegans* showed that Rpgrip1l form a complex with the Mks1, Mksr1, Mksr, Tmem67, Cc2d2a, Nphp1 and Nphp4 proteins. This complex establishes attachments between the basal body and the transition zone membrane and functions as a docking site to restrict vesicle fusion of vesicles containing ciliary proteins.^[@bib56]^ RPGRIP1L is highly expressed in adult human testis and kidney and in fetal eye, brain, and kidney.^[@bib57]^ JBTS7 is characterized by renal disease (NPHP) in addition to the classical neurological abnormalities of JS^[@bib55]^ ([Table 1](#tbl1){ref-type="table"}, [Figure 1](#fig1){ref-type="fig"}). Moreover, a case of COACH syndrome displaying ID, MTS, nephronophthisis and congenital hepatic fibrosis also displayed mutations in the *RPGRIP1* gene, which was defined as a COACH subtype of JS with liver involvement.^[@bib50]^ Furthermore, truncated mutations in this gene cause Meckel syndrome, a more severe phenotype (generally lethal). Overall, all reported *RPGRIP1* mutations are estimated to contribute to 2--4% of JSRDs,^[@bib8],[@bib55],[@bib57]^ and only one mutation has been found, in a Saudi Arabian family ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}).

*CC2D2A:* This gene encodes a component of a protein complex that comprises Mks1, Tmem216, Tmem67, Cep290, Rpgrip1l, Tctn1 and Tctn2, and it is located in the basal body of the cilia.^[@bib27],[@bib58]^ CC2D2A is highly expressed in prostate, pancreas, kidney, lung and liver tissues.^[@bib59]^ The phenotypic spectrum is highly variable, ranging from pure JS to JS associated with RP and COACH.^[@bib33],[@bib59]^ Mutations in this gene are responsible for 9% of all JSRDs.^[@bib33],[@bib50]^ Genotype--phenotype studies showed that null mutations result in the Meckel phenotype, whereas missense and/or hypomorphic mutations are responsible for JSRDs.^[@bib34],[@bib60]^ Furthermore, mutations in this gene were associated with ventriculomegaly and seizures in some cases.^[@bib35]^ A possible digenic inheritance has been reported in a Swiss patient with heterozygous mutations in the *CC2D2A* and *CEP41* genes, consistent with JBTS9 and JBTS15, respectively.^[@bib61]^ Similarly, a potential digenic inheritance in one Egyptian family was reported. The patient had heterozygous mutations in the *CC2D2A* and *TMEM67* genes, consistent with JBTS9 and JBTS6, respectively^[@bib62]^ ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}). Mutations in *CC2D2A* have been reported in Arabs from Saudi Arabia, Egypt, Algeria and Syria ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}).

*KIF7:* This gene encodes a cilia-associated protein belonging to the kinesin family that has a major role in the hedgehog signaling pathway and the regulation of microtubule acetylation and stabilization.^[@bib63],[@bib64]^ Individuals with *KIF7* mutations often have oro-facio-digital manifestations associated with or without agenesis/hypoplasia of the corpus callosum, hydrocephalus and macrocephaly. The digital anomalies consist of postaxial polydactyly of the hands and preaxial (and/or postaxial) polydactyly of the feet. Overlapping genetically related disorders include hydrolethalus syndrome (HLS; MIM [614120](http://www.omim.org/entry/614120?search=614120&highlight=614120)) and acrocallosal syndrome (ACLS; MIM [200990](http://www.omim.org/entry/200990?search=200990&highlight=200990)), with several patients exhibiting MTS along with features of HLS and ACLS, leading to diagnostic ambiguity.^[@bib65]^ ACLS is a rare disorder characterized by anencephaly as the primary manifestation together with a variety of developmental abnormalities, ID and preaxial polydactyly.^[@bib63],[@bib65]^ Patients displaying the major features of ACLS present with MTS, eliciting a subtype of JSRD and suggesting that ACLS and JBTS12 are overlapping ciliopathies.^[@bib65]^ HLS is a lethal disorder caused by mutation of the *HYLS1* gene, particularly in the Finnish population. A homozygous mutation was identified in *KIF7* in four affected fetuses of consanguineous Algerian pedigrees who showed the typical features of HLS in addition to MTS.^[@bib65]^ Additionally, digenic inheritance of heterozygous mutations in the *CEP290* and *KIF7* genes has been reported in a German patient with JS.^[@bib54]^ In another German patient, a heterozygous 12 bp deletion in *KIF7* and two missense mutations in *TMEM67* gene were detected.^[@bib63]^ Two Arab families from Egypt and Algeria were found to have mutations in *KIF7* ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}). In addition, a missense mutation in *KIF7* has been reported to cause an AR syndrome presenting with macrocephaly, multiple epiphyseal dysplasia and distinctive facial appearance in two Omani families.^[@bib66]^

*TCTN1:* This gene encodes Tectonic-1 that localizes to the membrane-spanning transition zone complex, a region between the basal body and the ciliary axoneme that regulates ciliogenesis.^[@bib58],[@bib67]^ Knockdown of *Tctn1* in mice resulted in lethal holoprosencephaly and disruption of the nodal flow, laterality defects and neural tube dorsalization. This finding suggests that Tctn1 plays a dual role in the repression and activation of the hedgehog signaling pathway.^[@bib67]^ Moreover, null mice for *Tcnt2* and *Cc2d2a* displayed similar phenotypes, suggesting a common role for these three genes in tissue-specific ciliogenesis.^[@bib58]^ Furthermore, Tctn1 has been shown to be a member of a JSRD and Meckel-associated protein complex, similar to Mks1, Tmem216, Tmem67, Cep290 Tctn2 and Cc2d2a. To date, only three pedigrees from Bangladesh and Saudi Arabia harboring *TCTN1* mutations have been reported ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}). JBTS13 patients display cerebellar vermis hypoplasia and MTS without renal or ophthalmological abnormalities.^[@bib58],[@bib68]^ Of note, only one case has been reported to exhibit bilateral fronto-temporal pachygyria and coarsening of the cerebral gyri.^[@bib58]^

*TCTN3*: This gene encodes tectonic-3, which is part of the transition zone complex at the cilium/plasma membrane border.^[@bib69]^ *TCTN3* was first linked to a severe prenatal form of OFD IV (Mohr--Majewski) syndrome characterized by long bone bowing, tibial hypoplasia, polydactyly, cystic kidneys, orofacial anomalies and encephalocele. Moreover, a less severe phenotype manifesting vermis agenesis and MTS as well as variable digital and axial skeletal anomalies, including kyphoscoliosis and horseshoe kidney,^[@bib69]^ was reported in a Turkish family with JSRD.^[@bib69]^ We report here a digenic inheritance in a non-consanguineous Emirati family (family JS_B); the father is Emirati, while the mother is Syrian. Two heterozygous missense mutations, p.R479S and p.I641N, were detected in *TCTN3* and *AHI1*, respectively, by exome sequencing ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}). Both mutations were novel, and computational analysis suggested that they are potentially pathogenic. Although TCTN3 is not critical for cilia biogenesis in the kidneys, this protein plays a major role in GLI3 processing and function in the sonic hedgehog pathway.^[@bib69]^

*CEP41:* This gene encodes a protein with two coiled-coil domains and a rhodanese-like domain that localizes to the centrioles and cilia.^[@bib61]^ Knockdown in zebrafish showed peripheral heart edema and tail defects, which is consistent with a ciliopathy.^[@bib61]^ In this organism, *Cep41* is expressed in various ciliary organs such as brain, ear, heart and kidney.^[@bib61]^ However, null mice demonstrated a wide phenotypic spectrum, ranging from wild type to exencephaly, dilated pericardial sac and lethality.^[@bib61]^ JBTS15 is characterized by ataxia, hypotonia, delayed psychomotor development, and ID with variable features, including breathing difficulties, polydactyly and oculomotor apraxia.^[@bib61]^ Moreover, some patients carrying *CEP41* mutations display retinal and kidney disease. All mutations identified in the *CEP41* gene are splice site mutations.^[@bib61]^ However, heterozygous mutations in *CEP41* associated with heterozygous mutations in other ciliary genes (such as *KIF7* and *CC2D2A*) have been detected in patients with JS, BBS and Meckel syndromes.^[@bib61]^ These findings suggest possible digenic inheritance and a role for *CEP41* as a modifier gene in other ciliopathies.^[@bib61]^ A single mutation in this gene was reported in two Arab families with JSRDs from Egypt ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}).

*C5orf42:* This gene encodes a protein of unknown function that has features of a transmembrane protein and a putative coiled-coil domain.^[@bib70]^ This protein is expressed in a broad variety of tissues and might play a role in neurodevelopment. Several compound heterozygous mutations have been detected in unrelated families of French-Canadian descent with JBTS17.^[@bib70]^ The clinical manifestations showed a distinct phenotype that most closely resembles a pure JS with an absence of retinal or renal involvement.^[@bib70],[@bib71]^ Only one case has been reported to exhibit preaxial and postaxial polydactyly.^[@bib70]^ This gene is the cause of JS in the original family reported by Joubert *et al.*^[@bib9]^ in 1969. Three families from Saudi Arabia carrying one possible founder mutation (p.G2663Afs\*40) have been reported ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}).

*CSPP1*: This gene encodes a protein that localizes to microtubules that accumulate around the centrosome.^[@bib72]^ CSPP1 is highly expressed in both the adult and fetal human brain, particularly in the cerebellum.^[@bib72]^ Knockdown of *cspp1a* in zebrafish results in a curved body shape, dilated ventricles and pronephric cysts, which is consistent with a ciliopathy.^[@bib73]^ JBTS21 is characterized by MTS, hypotonia, developmental delay, eye movement abnormalities and abnormal breathing.^[@bib73; @bib74; @bib75]^ However, some cases display features of asphyxiating thoracic dystrophy (Jeune syndrome).^[@bib73]^ Immunostaining of patients' fibroblasts revealed defects in ciliogenesis and evidence of decreased trafficking of the ciliary proteins ARL13B and ADCY3 to the axoneme compared with controls.^[@bib73]^ Three Arab families from Saudi Arabia, Lebanon and Libya carrying mutations in *CSPP1* have been reported ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}). The patients from Saudi Arabia showed more severe phenotypes that were characterized by hydranencephaly, occipital encephalocele, wide cranial sutures, anophthalmia, single nostril and hyperechogenic kidneys.^[@bib74]^

JS and JSRDS are genotypically heterogeneous in Arab populations
================================================================

We have presented a comprehensive review of the genes and mutations causing JS and JSRDs in Arab families. Despite the high level of consanguinity and the presence of isolated communities within most Arab populations, there is considerable genetic and allelic heterogeneity within these populations with only a few potential founder mutations ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}).

To date, 23 genes have been linked to the broad phenotypic spectrum of JS, with potentially more genes remaining unknown. Mutations in 15 of these genes have been reported in Arab families ([Table 2](#tbl2){ref-type="table"}). Interestingly, the most common mutated genes in Arabs are *INPP5E, AHI1, CEP290, CC2D2A* and *TMEM138* ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}), each with suspected founder mutations. Moreover, some genes have a high incidence in a particular region or country compared with the other ciliopathy genes. For example, mutations in *KIF7* and *TMEM67* are found primarily in North African Arab countries ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}). On the other hand, mutations in *C5orf42* and *RPGRIP1L* have only been detected in Saudi Arabia. Mutations in *AHI1* and *CEP290* predominantly occur in the Arabian Gulf region ([Figure 2](#fig2){ref-type="fig"}). It is worth noting that mutations in *TCTN1* have been found exclusively in Arab families thus far ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}, and [Figure 3](#fig3){ref-type="fig"}). Overall, the incidence of these mutations in Arabs is not very high; therefore, each of these genes should be considered relevant when dealing with suspected cases ([Table 2](#tbl2){ref-type="table"}, [Figure 2](#fig2){ref-type="fig"}, and [Figure 3](#fig3){ref-type="fig"}).

Conclusions
===========

This review has focused on the genes and mutations involved in JSRDs among Arabs. We found a wide genetic and genotypic heterogeneity along the JS spectrum and JSRDs in Arabs. Most of the underlying genes encode proteins expressed in the primary cilium and/or basal body and centrosome. Physical interactions between several ciliary proteins have been shown; however, the exact signaling mechanisms and disrupted developmental pathways remain unclear. Moreover, the link between ciliogenesis and brain development is still not well defined. Therefore, identifying the molecular pathogenesis associated with JSRDs could alter prognosis and medical management and provide preventive guidance for these ciliopathies. Many of the ciliary genes described above are not available for clinical testing but can instead be studied in research laboratories. Owing to the diversity of genes and mutations underlying JSRDs, whole exome and/or whole genome sequencing may be an appropriate starting point for molecular diagnosis. We anticipate that many families with JSRDs in Arab countries remain unstudied; therefore, the spectrum and distribution of the causative mutations might change as we learn more about this condition. This review should be of significant importance to clinicians and scientists working on genetic conditions in Arab populations.
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![Clinical subtypes of JSRD adopted from Brancati *et al.* ^[@bib17]^ The clinical classification scheme should not be considered as final given the extreme clinical variation and the variable onset of different features. Bold: major gene; CHS: congenital hepatic fibrosis; COACH: cerebellar vermis hypoplasia, oligophrenia, ataxia, coloboma and hepatic fibrosis; CORS: cerebello-oculo-renal syndromes; JS: Joubert syndrome; LCA: Leber congenital Amaurosis; MTS: molar tooth sign; NPHP: nephronophthisis.](hgv201420-f1){#fig1}

![Distribution of all reported mutations in JSRD-associated genes in the Arab world. The Arab world map showing the different distribution of genes and mutations responsible for Joubert and related conditions in the Arab populations. Bold: presumed founder mutations; ^c´^Compound heterozygous mutations; ^**Đ**^digenic inheritance; del: deletion; Fs: frameshift; \*stop codon.](hgv201420-f2){#fig2}

![Percentage of reported mutations in Arab populations per total mutations in each gene. The bar chart represents the percentage of mutations reported in this study and extracted from the HGMD database (<http://www.biobase-international.com/product/hgmd>) in Arab populations per total reported mutations in each gene individually.](hgv201420-f3){#fig3}

###### List of genes responsible for JS and JSRDs among the Arabs

  *JS Type*   *Gene symbol*   *Protein name*                                    *Locus*        *Inheritance*   *Alternative names*                                                                                                                                                             *Phenotype MIM nb.*
  ----------- --------------- ------------------------------------------------- -------------- --------------- --------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------
  JBTS1       *INPP5E*        Inositol polyphosphate 5-phosphatase              9q34.3         AR              Joubert--Boltshauser syndrome Cerebelloparenchymal disorder iv; CPD4 Cerebellooculorenal syndrome 1; CORS1                                           [213300](http://www.omim.org/entry/213300?search=213300&highlight=213300)
  JBTS3       *AHI1*          Jouberin                                          6q23.3         AR                                                                                                                                                                   [608629](http://www.omim.org/entry/608629?search=608629&highlight=608629)
  JBTS4       *NPHP1*         Nephrocystin-1                                    2q13           AR                                                                                                                                                                   [609583](http://www.omim.org/entry/609583?search=609583&highlight=609583)
  JBTS5       *CEP290*        Centrosomal protein of 290 kDa                    12q21.32       AR                                                                                                                                                                   [610188](http://www.omim.org/entry/610188?search=610188&highlight=610188)
  JBTS6       *TMEM67*        Meckelin                                          8q22.1         AR                                                                                                                                                                   [610688](http://www.omim.org/entry/610688?search=610688&highlight=610688)
  JBTS7       *RPGRIP1L*      Protein fantom                                    16q12.2        AR                                                                                                                                                                   [611560](http://www.omim.org/entry/611560?search=611560&highlight=611560)
  JBTS9       *CC2D2A*        Coiled-coil and C2 domain containing protein 2A   4p15.32                        Joubert syndrome 9/15, digenic, included                                                                                                             [612285](http://www.omim.org/entry/612285?search=612285&highlight=612285)
  JBTS12      *KIF7*          Kinesin-like protein KIF7                         15q26.1        AR              Hallux duplication, postaxial polydactyly and absence of corpus callosum Schinzel Acrocallosal syndrome Joubert syndrome 12/15, digenic, included    [200990](http://www.omim.org/entry/200990?search=200990&highlight=200990)
  JBTS13      *TCTN1*         Tectonic-1                                        12q24.11       AR                                                                                                                                                                   [614173](http://www.omim.org/entry/614173?search=614173&highlight=614173)
  JBTS14      *TMEM237*       Transmembrane protein 237                         2q33.1         AR                                                                                                                                                                   [614424](http://www.omim.org/entry/614424?search=614424&highlight=614424)
  JBTS15      *CEP41*         Centrosomal protein of 41 kDa                     7q32.2         AR              Joubert syndrome 12/15, digenic, included                                                                                                            [614464](http://www.omim.org/entry/614464?search=614464&highlight=614464)
  JBTS16      *TMEM138*       Transmembrane protein 138                         11q12.2        AR                                                                                                                                                                   [614465](http://www.omim.org/entry/614465?search=614465&highlight=614465)
  JBTS17      *C5orf42*       Uncharacterized protein                           5p13.2         AR                                                                                                                                                                   [614615](http://www.omim.org/entry/614615?search=614615&highlight=614615)
  JBTS18      *TCTN3*         Tectonic 3                                        10q24.1        AR                                                                                                                                                                   [614815](http://www.omim.org/entry/614815?search=614815&highlight=614815)
  TBTS21      *CSPP1*         centrosome/spindle pole-associated protein        8q13.1-q13.2   AR                                                                                                                                                                   [615636](http://www.omim.org/entry/615636?search=615636&highlight=615636)

Abbreviations: AR, autosomal recessive; nb, number; JBTS, Joubert syndrome.

###### List of pathogenic mutations responsible for JS and JSRDs among Arabs

  *JS type*   *Genes*      *Fam. ID*           *No. Aff.*    *Allele*  *DNA change*                *Pt. change*              *Cons.*   *Note*    *Ethnicity*               *Reference*
  ----------- ------------ ----------------- -------------- ---------- --------------------------- ------------------------- --------- --------- ------------------------ -------------
  JBTS1       *INPP5E*     MTI-007 MTI-134    5 (1 died) 1      CH     c.1537C\>T c.1543G\>A       p.R512W **p.R515W**       Yes                 Emirati (Omani)            ^[@bib1]^
                           MTI-498                 1            H      c.1543G\>A                  **p.R515W**               Yes                 Emirati (Omani)           This study
                           JS_D                    1            H      c.1535G\>A                  p.R512Q                   Yes                 Yamani                    This study
                           JBS-011                 2            CH     c.1600T\>G c.1862G\>A       p.Y534D p.R621Q           No                  Algerian                   ^[@bib2]^
                           MTI-008                 4            H      c.1688G\>A                  p.R563H                   Yes                 Emirati                    ^[@bib1]^
                           MTI-627             3 (1 died)       H      c.1738A\>G                  p.K580E                   Yes                 Egyptian                   ^[@bib1]^
                           MTI-888                 2            H      **c.1921T\>C**              **p.C641R**               Yes                 Egyptian                   ^[@bib2]^
                           MTI-1521                2            H      **c.1921T\>C**              **p.C641R**               Yes                 Egyptian                   ^[@bib2]^
  JBTS3       *AHI1*       Pedigree 1              3            H      **c.1051C\>T**              **p.R351\***              Yes                 Saudi                      ^[@bib3]^
                           JS_A                    1            H      **c.1051C\>T**              **p.R351\***              Yes                 Emirati                   This study
                           Pedigree 2              2                   c.1303C\>T                  p.R435\*                  Yes                 Saudi                      ^[@bib3]^
                           JS_F2                   1            H      **c.1328T\>A**              **p.V443D**               Yes                 Saudi                      ^[@bib4]^
                           JS_F10                  2            H      **c.1328T\>A**              **p.V443D**               Yes                 Saudi                      ^[@bib4]^
                           Pedigree 3              1            H      **c.1328T\>A**              **p.V443D**               Yes                 Saudi                      ^[@bib3]^
                           115                     2            H      **c.1328T\>A**              **p.V443D**               Yes                 Kuwaiti                    ^[@bib5]^
                           MTI-1501                1            H      **c.1922T\>A**              **p.I641N**               Yes       novel     Emirati                   This study
                           [JS_B]{.ul}             2            Ht     c.1922T\>A                  **p.I641N**               No        digenic   F (Emirati) M (Syrian)    This study
                           K8103                   2            H      c.2156A\>G                  p.D719G                   Yes                 Saudi                      ^[@bib6]^
                           MTI-115                 2            H      c.1190_1191delTG            Fs\*408                   Yes                 Kuwaiti                    ^[@bib5]^
                           ND                      ND           ND     c.3263_3264delGG            ND                        Yes                 Egyptian                   ^[@bib7]^
                           MTI-10                  1            H      c.787dupC                   Fs\*270                   Yes                 Palestinian                ^[@bib5]^
  JBTS4       *NPHP1*      A2229                   1            H      c.143G\>A                   p.R48K                    Yes                 Arab                     
  JBTS5       *CEP290*     A1332                   1            Ht     c.164_167delCTCA            p.T55fsX57                Yes                 Syrian                     ^[@bib8]^
                           JS_3                    1            H      c.4714G\>T                  p.E1572\*                 Yes                 Saudi                      ^[@bib4]^
                           JS_F11                  1            H      **c.5668G\>T**              **p.G1890\***             Yes                 Emirati                    ^[@bib9]^
                           JS_F12                  1            H      **c.5668G\>T**              **p.G1890\***             Yes                 Saudi                     ^[@bib10]^
                           JS_C                                 H      **c.5668G\>T**              **p.G1890\***             Yes                 Omani                     This study
                           MTI-587                 1            H      **c.5668G\>T**              **p.G1890\***             Yes                 Emirati                   This study
                           MTI-012                 1            H      **c.5668G\>T**              **p.G1890\***             Yes                 Emirati                   This study
                           MTI-1001                3            CH     **c.5668G\>T** c.5932G\>A   **p.G1890\*** p.R1978\*   No        novel     Emirati                   This study
                           MTI-133             2 (2 died)       H      c.5824C\>T                  p.Q1942\*                 Yes                 Palestinian               ^[@bib11]^
  JBTS6       *TMEM67*     A1371                   2            H      c.1888T\>C                  p.S630P                   Yes                 Moroccan                  ^[@bib12]^
                           [A1421-21]{.ul}         ND           Ht     c.2461G\>A                  p.G821S                   No        digenic   Egyptian                  ^[@bib13]^
                           JS-05                   1            H      c.2439+5G\>C                p.I775_A813del            ND                  Algerian                  ^[@bib14]^
  JBTS7       *RPGRIP1L*   JS_F1                   3            H      c.1649A\>G                  p.Q550R                   Yes                 Saudi                      ^[@bib4]^
  JBTS9       *CC2D2A*     JBS-006                 1            H      c.2161C\>T                  p.P721S                   Yes                 Algerian                  ^[@bib15]^
                           [A1421-21]{.ul}         1            Ht     **c.3055C\>T**              **p.R1019\***             No        digenic   Egyptian                  ^[@bib13]^
                           [ND]{.ul}               ND           H      **c.3056G\>A**              **p.R1019\***             Yes                 Egyptian                 
                           UW36                    1                   **c.3364C\>T**              **p.P1122S**              Yes                 Saudi                     ^[@bib16]^
                           UW48                3 (2 died)              **c.3364C\>T**              **p.P1122S**              Yes                 Saudi                     ^[@bib16]^
                           F871                    1            H      c.4652T\>C                  p.L1551P                  Yes                 Saudi                     ^[@bib16]^
                           UW50                    2                   c.4582C\>T                  p.R1528C                  Yes                 Levarten Arab             ^[@bib16]^
                           MTI-127                 1            CH     c.4258G\>A c.1412delG       p.R1528H p.K472Rfs\*      Yes       Novel     Emirati                   This study
  JBTS12      *KIF7*       E                       2            H      c.217delG                   p.A73Pfs\*109             Yes                 Egyptian                  ^[@bib17]^
                           Fam9                    1            H      c.233_234del                p.L78Pfs\*2               Yes                 Egyptian                  ^[@bib18]^
                           Fam1                    3            H      **c.2896_2897del**          **p.A966Pfs\*81**         Yes                 Algerian                  ^[@bib18]^
                           Fam8                    1            H      **c.2896_2897del**          **p.A966Pfs\*81**         Yes                 Algerian                  ^[@bib18]^
  JBTS13      *TCTN1*      E1 & E2                 2                   c.217delG                   ND                        Yes                 Egyptian                  ^[@bib17]^
                           JS_F8                   2                   **c.342-2A\>G**             **p.G115Kfs\*8**          Yes                 Saudi                      ^[@bib4]^
                           JS_F9                   1                   **c.342-2A\>G**             **p.G115Kfs\*8**          Yes                 Saudi                      ^[@bib4]^
  JBTS14      *TMEM237*    Family L                1                   c.1066dupC                  p.Q356Pfs\*23             Yes                 Jordanian                 ^[@bib19]^
                           JS_F4                   2                   **c.869+1G\>A**             ND                        Yes                 Saudi                      ^[@bib4]^
                           MTI-131                 2            H      c.953_954AGdel              p.Q318Pfs\*5              Yes       novel     Emirati                   This study
  JBTS15      *CEP41*      MTI-429             5 (1 died)       H      c.33+2T\>G                  ND                        Yes                 Egyptian                  ^[@bib20]^
                           MTI-1491                2            H      c.97+3_97+5delGAG           ND                        Yes                 Egyptian                  ^[@bib20]^
  JBTS16      *TMEM138*    MTI-656                 1                   **c.376G\>A**               **p.A126T**               Yes                 Egyptian                  ^[@bib21]^
                           MTI-998                 1                   **c.376G\>A**               **p.A126T**               Yes                 Egyptian                  ^[@bib21]^
                           MTI-129                 3                   c.380C\>T                   p.A127V                   Yes                 Emirati                   ^[@bib21]^
                           MTI-499             7 (6 died)              **c.389A\>G**               **p.Y130C**               Yes                 Oman                      ^[@bib21]^
                           JS_D                    2                   **c.389A\>G**               **p.Y130C**               Yes                 Emirati                   This study
                           MTI-1479                1                   **c.389A\>G**               **p.Y130C**               Yes                 Emirati                   This study
                           MTI-006                 2                   **c.128+5G\>A**             ND                        Yes                 Emirati                   ^[@bib21]^
                           MTI-381             3 (1 died)              **c.128+5G\>A**             ND                        ND        OFD VI    Emirati                   ^[@bib21]^
  JBTS17      *C5orf42*    JS_F5                   1                   c.7978C\>T                  p.R2660\*                 Yes                 Saudi                      ^[@bib4]^
                           JS_F6                   2                   **c.7988_7989delGA**        **p.G2663Afs\*40**        Yes                 Saudi                      ^[@bib4]^
                           JS_F7                   2                   **c.7988_7989delGA**        **p.G2663Afs\*40**        Yes                 Saudi                      ^[@bib4]^
  JBTS18      *TCTN3*      [JS_B]{.ul}             2                   c.1437G\>C                  p.R479S                   No        digenic   F (Emirati) M (Syrian)    This study
  JBTS21      *CSPP1*      ND                      1            H      c.2527_2528delAT            p.M843Efs\*25             Yes                 Lebanese                  ^[@bib22]^
                           ND                  3 (1 died)       H      c.2244_2247delAAGA          p.E750Lfs\*7              Yes                 Saudi                     ^[@bib23]^
                           ND                      1            H      c.2773C\>T                  p.R925\*                  Yes                 Libyan                    ^[@bib24]^

Underline, families with digenic inheritance; bold, suspected founder mutations.

Abbreviations: Aff., Affected; CH, compound heterozygous; Cons, consanguinity; F, Female; Fam, family; H, Homozygous; Ht, Heterozygous; JBTS, JS, Joubert Syndrome; M, Male; ND, not determined; No, Number; Pt, Protein; fs, frameshift; \* Stop codon.
